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Abstract
We report the detection and molecular characterization of
extended spectrum b-lactamases in a series of 112 clinical isolates
of Enterobacteriaceae from the Ho^pital Principal de Dakar, Senegal,
including five CTX-M-15-producing Morganella morganii isolates,
which are reported for the first time in this country.
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Introduction
Over the last 30 years, hospital-acquired infections caused by
Gram-negative bacilli, especially Enterobacteriaceae, have
become a worldwide problem as a result of the misuse of
antibiotics and poor hospital hygiene [1]. Indeed, in health
facilities, these opportunistic pathogens are responsible for
nosocomial infections including hospital-acquired pneumonia,
urinary tract infections, bloodstream infections and wound
infections [2,3]. The increase in these infections has been
mainly associated with the widespread dissemination of
multidrug-resistant bacteria that are highly resistant to the
common antibiotics used for the treatment of these infections
[4]. However, while the dissemination and high prevalence of
antibiotic resistance in Gram-negative bacilli has been
described worldwide and could be associated with interna-
tional travel and tourism [5], few studies have described the
prevalence and mechanism of antibiotic resistance in Entero-
bacteriaceae from northern Africa, especially Senegal [3].
Indeed, the few studies conducted in this region were on
Enterobacteriaceae species including Shigella flexneri and Salmo-
nella enterica, which are not classified as dominant nosocomial
pathogens [6,7]. In this region, we have recently described the
emergence of clinical multidrug-resistant Gram-negative
bacteria, especially Acinetobacter baumannii, resistant to all
b-lactams including the carbapenems [8], which has never been
reported before in Senegal. Therefore, because of the
emergence of multidrug-resistant bacilli such as A. baumannii
and the paucity of studies focused on antibiotic resistance in
clinical nosocomial pathogens, we conducted an epidemiolog-
ical study to describe the prevalence and dissemination of
antibiotic resistance genes in a large collection of clinical
Enterobacteriaceae strains isolated from the Ho^pital Principal de
Dakar, Senegal.
Methods
All clinical Enterobacteriaceae isolated and studied here were
collected from hospitalized patients between October and
December 2011 in the Ho^pital Principal de Dakar, Senegal. All
of them were isolated from blood cultures, urine samples,
superficial pus, protected bronchial samples, or catheters.
Bacteria were grown on trypticase soy or M€uller–Hinton
media for 24 h at 37°C. Bacterial identification was performed
using both standard phenotypic methods including API 20E
gallery (BioMerieux, Marcy l’Etoile, France) and matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF MS) (Autoflex, Bruker Daltonic, Bremen, Ger-
many) with the FLEX CONTROL software (Bruker Daltonic).
MALDI-TOF MS identification to species level was validated
with score values ≥1.9 as previously reported [9]. Antibiotic
susceptibility testing was performed by the disk diffusion
method as well as by the Etest (AB Biodisk, Solna, Sweden)
method. Thirteen antibiotic disks—amoxicillin, amoxicillin/
clavulanic acid, ticarcillin, ceftriaxone, cefpirome, cefepime,
imipenem, gentamicin, netilmicin, tobramycin, colistin, peflox-
acin and nalidixic acid—were used (Bio-Rad, Marnes la
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Coquette, France) on M€uller–Hinton agar according to the
recommendations of the Comite de l’antibiogramme de la
Societe Francaise de Microbiologie (CASFM) (http://www.
sfm-microbiologie.org/). The antibiotic susceptibility results
were interpreted according to the guidelines of the CASFM.
The major and predominant extended-spectrum b-lactamase
(ESBL) -encoding genes, including blaTEM, blaSHV and blaCTX-M,
were investigated by standard PCR and sequencing using
previously described primers [10–12].
Results
Phenotypic properties of the strains
One hundred and twelve clinical isolates were studied
including Morganella morganii (n = 5), Escherichia coli (n = 30),
Enterobacter cloacae (n = 13) and Klebsiella pneumoniae
(n = 64). Forty-three (38%) strains were isolated from blood
cultures, 41 (37%) were from urine samples, 17 (15%) were
from pus and 11 (10%) were from an assortment of samples
including bronchoalveolar lavage fluid, catheters and protected
bronchial samples (Fig. 1). The identification score values from
MALDI-TOF was at least 1.90 for all isolates and therefore all
strains were identified to species level, as shown in the
MALDI-TOF dendrogram (Fig. 1). The antibiotic susceptibility
testing reveals a high incidence of resistance to b-lactam drugs,
and up to 90% of isolates were resistant to amoxicillin,
amoxicillin/clavulanic acid, ticarcillin and ceftriaxone; 58% of
the isolates were resistant to cefepime, but all of them were
susceptible to imipenem (Fig. 2a). A more variable incidence of
resistance to the other antibiotic families was observed
(Fig. 2a). As shown in Fig. 2(a), colistin resistance was
observed only in M. morganii isolates, which are naturally
resistant to this antibiotic drug. Interestingly, as observed from
the antibiotic susceptibility testing results, the resistance
phenotype of some isolates to the third (ceftriaxone) and
fourth (cefpirome) generations of cephalosporins suggests the
presence and expression of ESBL-encoding genes in these
isolates.
Molecular investigation of b-lactamase-encoding genes
The standard PCR and sequencing analysis using universal
primers targeting all blaTEM, blaSHV and blaCTX-M genes revealed
the surprising presence of the blaCTX-M-15 ESBL-encoding gene
in all 112 isolates (Fig. 2b; see Supporting information, Table
S1). Fifty-four and 57 out of the 64 strains of K. pneumoniae
harboured the blaTEM-1 and blaSHV genes, respectively, includ-
ing blaSHV-11, blaSHV-12 and blaSHV-28 (Fig. 2b; Table S1). Four
and 18 out of the 30 E. coli isolates, respectively, harboured
the blaTEM-1 and blaSHV genes. Among the 13 Enterobacter
cloacae isolates, two harboured blaSHV genes and 11 harboured
the blaTEM-1 gene; finally, three of the five M. morganii
harboured the blaTEM-1 gene and no blaSHV genes were found
in these isolates (Fig. 2b; Table S1).
FIG. 1. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry dendrogram and isolation sources of the strains.
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Discussion
To the best of our knowledge, CTX-M-15-producing M. mor-
ganii isolates are reported herein for the first time in Senegal.
There are only two reports of CTX-M-15-producing
Enterobacteriaceae in clinical isolates in Senegal, including 45
K. pneumoniae, one E. coli and one Enterobacter cloacae [13,14]
isolates. Hence, in the present study, we report the largest
series of CTX-M-15-producing Enterobacteriaceae from
Senegal, showing a high prevalence and dissemination of the
CTX-M-15 ESBL-encoding gene in this hospital. Furthermore,
this study highlights a probable outbreak concerning K. pneu-
moniae isolates as >60% of the isolates harboured simulta-
neously the three genes blaTEM-1, blaCTX-M-15 and blaSHV-28.
This finding is very disturbing because no previous studies have
focused on monitoring the prevalence and dissemination of
antibiotic resistance genes in this important Dakar hospital.
The presence of ESBLs in M. morganii is also worrying because
these bacteria are intrinsically resistant to colistin. As we have
(a)
(b)
FIG. 2. Antibiotic resistance pattern (a) and b-lactamase encoding genes detected in isolates (b). AM, amoxicillin; AMC, amoxicillin/clavulanic acid;
TIC, ticarcillin; CRO, ceftriaxone; FOX, cefpirome; FEP, cefepime; IPM, imipenem; GN, gentamicin; NET, netilmicin, TM, tobramycin; CS, colistin;
PEF, pefloxacin; NA, nalidixic acid; S, susceptible; R, resistant; I, intermediate; ND, not determined.
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also recently described the emergence of the OXA-23
carbapenemase gene in multidrug-resistant A. baumannii iso-
lates from this hospital [8] as well as the recent emergence of
class D OXA-48 carbapenemase in Enterobacteriaceae in
Senegal [13], it is urgent that local authorities are alerted to
this problem to avoid the widespread dissemination of
antibiotic-resistance genes and multidrug-resistant bacteria in
all hospitals in Senegal.
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